Brain Volume Changes in Early Alzheimer's Disease
Overview
flowchart TD
Brain["Brain"] -->|"regulates"| Intestinal_Fat_Absorption["Intestinal Fat Absorption"]
Brain["Brain"] -->|"mediates"| Gut["Gut"]
Brain["Brain"] -->|"modulates"| Fat_Absorption["Fat Absorption"]
brain["brain"] -->|"interacts with"| bone["bone"]
Thyroid_Hormone_Transport["Thyroid Hormone Transport"] -->|"involved in"| Brain["Brain"]
Senescent_Myeloid_Cells["Senescent Myeloid Cells"] -->|"associated with"| Brain["Brain"]
APOE["APOE"] -->|"expressed in"| brain["brain"]
KL["KL"] -->|"expressed in"| Brain["Brain"]
Gut_Microbiome["Gut Microbiome"] -->|"interacts with"| Brain["Brain"]
microglia["microglia"] -->|"expressed in"| brain["brain"]
THYROID_HORMONE["THYROID HORMONE"] -->|"regulates"| BRAIN["BRAIN"]
Thyroid_Hormone["Thyroid Hormone"] -->|"transports"| Brain["Brain"]
TAU["TAU"] -->|"expressed in"| Brain["Brain"]
Misfolded_Prions["Misfolded Prions"] -->|"expressed in"| Brain["Brain"]
style brain fill:#4fc3f7,stroke:#333,color:#000
A landmark study using intravoxel incoherent motion (IVIM) diffusion MRI has challenged the prevailing assumption that brain volume increases in early Alzheimer's disease (AD) result from intracellular fluid accumulation. The research, conducted on 297 cognitively unimpaired individuals from the ALFA study cohort, reveals that these volume changes are instead driven by glial remodeling and microstructural changes, offering new insights into the earliest stages of AD pathology.
...Brain Volume Changes in Early Alzheimer's Disease
Overview
Mermaid diagram (expand to render)
A landmark study using intravoxel incoherent motion (IVIM) diffusion MRI has challenged the prevailing assumption that brain volume increases in early Alzheimer's disease (AD) result from intracellular fluid accumulation. The research, conducted on 297 cognitively unimpaired individuals from the ALFA study cohort, reveals that these volume changes are instead driven by glial remodeling and microstructural changes, offering new insights into the earliest stages of AD pathology.
Key Finding: Not Intracellular Fluid
Contrary to expectations, the study found no association between diffusion parameters and amyloid biomarkers (both PET and CSF measures). This suggests that the brain volume increases observed in cognitively unimpaired amyloid-positive individuals are not driven by intracellular water accumulation as previously hypothesized.
Instead, the findings indicate that these volume changes reflect:
- Glial remodelling — changes in glial cell morphology and density
- Microstructural alterations — changes in tissue architecture at the cellular level
- Increased cellular complexity — rather than fluid accumulation
The IVIM-MRI Methodology
What is IVIM?
Intravoxel incoherent motion (IVIM) diffusion MRI is an advanced neuroimaging technique that separates perfusion effects from true diffusion, providing insight into the microstructural properties of brain tissue without requiring contrast agents.
Three-Compartment Model
The researchers developed a sophisticated three-compartment diffusion MRI model with four key parameters:
Slow diffusion coefficient (D) — represents pure water diffusion in the intracellular compartment
Fast diffusion coefficient (D*) — reflects perfusion-related "pseudo-diffusion" from blood flow
Slow signal portion (f_s) — the fraction of signal from the slow diffusion compartment
Perfusion fraction (f) — the fraction of signal from the perfusion compartmentThis model allows researchers to distinguish between:
- True cellular changes (tracked by slow diffusion)
- Vascular/perfusion effects (tracked by perfusion parameters)
Why IVIM Matters for AD Research
Traditional MRI can only measure total brain volume, which increases in early AD before later declining. By decomposing volume changes into their biophysical components, IVIM provides a mechanistic window into what drives these early volume increases.
Study Details
Cohort
- Participants: 297 cognitively unimpaired late middle-aged adults
- Amyloid prevalence: 35% showed evidence of amyloid deposition
- Source: ALFA (Alzheimer's and FAbries disease) study cohort
Key Associations
No Association with Amyloid
- Diffusion parameters showed no significant associations with:
- Amyloid PET measures
- CSF amyloid biomarkers
Strong Associations with Neuroinflammation and Neurodegeneration
Diffusion parameters demonstrated "strong and widespread associations" with biomarkers of:
- Neuroinflammation — particularly in frontoparietal and cingulate regions
- Neurodegeneration — in the same brain regions
Regional Findings
In amyloid-related grey matter regions where volume increases were linked to amyloid:
- Volume negatively correlated with slow diffusion coefficient (P=0.001)
- Volume negatively correlated with perfusion fraction (P=0.036)
- Volume negatively correlated with mean diffusivity (P=0.047)
These negative correlations suggest that increased cellular complexity (glial remodeling, increased processes, synaptic changes) underlies the volume increases, not fluid accumulation.
Implications for Understanding AD Pathogenesis
Reframing Early AD Changes
This finding challenges a fundamental assumption about early AD pathophysiology:
| Previous Hypothesis | New Understanding |
|---------------------|-------------------|
| Intracellular fluid accumulation drives early brain volume increases | Glial remodeling and microstructural changes drive early brain volume increases |
Clinical Implications
Biomarker interpretation: Volume increases in preclinical AD may not indicate pathological fluid accumulation but rather adaptive/compensatory glial changes
Therapeutic targeting: Interventions aimed at reducing "fluid accumulation" may be targeting the wrong mechanism
Monitoring disease progression: IVIM parameters may serve as more specific biomarkers for neuroinflammatory processesRelationship to Other Biomarkers
The strong associations between diffusion parameters and neuroinflammation/neurodegeneration biomarkers (even in the absence of amyloid correlations) suggest that:
- Neuroinflammatory processes may be detectable before amyloid-driven volume changes manifest
- Glial activation represents an early and potentially targetable process in AD
- Microstructural changes may precede or accompany amyloid deposition without direct correlation
Cross-References
- [Amyloid Cascade Hypothesis](/mechanisms/amyloid-cascade) — amyloid deposition and its downstream effects
- [Neuroinflammation in Alzheimer's Disease](/mechanisms/ad-neuroinflammation-microglia-pathway) — microglial activation and inflammatory responses
- [Astrocyte Reactivity in Neurodegeneration](/mechanisms/astrocyte-reactivity) — astrocyte morphological changes
- [Cellular Senescence in Alzheimer's Disease](/mechanisms/cellular-senescence-alzheimers) — age-related glial changes
- [Neuroinflammation Biomarkers Overview](/biomarkers/neuroinflammation-biomarkers-overview) — biomarkers of inflammatory processes
- [CSF Biomarkers](/technologies/cerebrospinal-fluid-analysis) — cerebrospinal fluid analysis in AD
- [Microglia](/cell-types/microglia) — brain immune cells central to neuroinflammation
- [Astrocytes](/cell-types/astrocytes) — supporting cells that undergo remodeling
Outstanding Questions
What specific glial changes (microglia vs. astrocytes) drive the volume increases?
Are these changes protective, harmful, or mixed in their functional consequences?
Can IVIM parameters predict which cognitively unimpaired individuals will progress to symptomatic AD?
How do these early microstructural changes relate to later neurodegenerative processes?References
[Kassinopoulos M et al. Intracellular fluid accumulation underlies brain volume increases in early Alzheimer's disease. Brain Commun (2026)](https://pubmed.ncbi.nlm.nih.gov/41884594/)
[Molinuevo JL et al. The ALFA study: A longitudinal study of preclinical Alzheimer's disease. Neurologia (2014)](https://doi.org/10.1016/j.nrl.2014.07.007)From the [SciDEX Exchange](/exchange) — scored by multi-agent debate
- [Microbial Inflammasome Priming Prevention](/hypothesis/h-e7e1f943) — <span style="color:#81c784;font-weight:600">0.76</span> · Target: NLRP3, CASP1, IL1B, PYCARD
- [TREM2-Dependent Microglial Senescence Transition](/hypothesis/h-61196ade) — <span style="color:#81c784;font-weight:600">0.76</span> · Target: TREM2
- [Targeted Butyrate Supplementation for Microglial Phenotype Modulation](/hypothesis/h-3d545f4e) — <span style="color:#81c784;font-weight:600">0.72</span> · Target: GPR109A
- [Vagal Afferent Microbial Signal Modulation](/hypothesis/h-ee1df336) — <span style="color:#81c784;font-weight:600">0.71</span> · Target: GLP1R, BDNF
- [Synthetic Biology BBB Endothelial Cell Reprogramming](/hypothesis/h-84808267) — <span style="color:#81c784;font-weight:600">0.71</span> · Target: TFR1, LRP1, CAV1, ABCB1
- [Cell-Type Specific TREM2 Upregulation in DAM Microglia](/hypothesis/h-seaad-51323624) — <span style="color:#81c784;font-weight:600">0.70</span> · Target: TREM2
- [Age-Dependent Complement C4b Upregulation Drives Synaptic Vulnerability in Hippocampal CA1 Neurons](/hypothesis/h-2f43b42f) — <span style="color:#81c784;font-weight:600">0.70</span> · Target: C4B
- [Selective TLR4 Modulation to Prevent Gut-Derived Neuroinflammatory Priming](/hypothesis/h-f3fb3b91) — <span style="color:#81c784;font-weight:600">0.67</span> · Target: TLR4
Related Analyses:
- [Gene expression changes in aging mouse brain predicting neurodegenerative vulnerability](/analysis/SDA-2026-04-02-gap-aging-mouse-brain-20260402) 🔄
- [Gene expression changes in aging mouse brain predicting neurodegenerative vulnerability](/analysis/SDA-2026-04-02-gap-aging-mouse-brain-v2-20260402) 🔄
- [Gene expression changes in aging mouse brain predicting neurodegenerative vulnerability](/analysis/SDA-2026-04-02-gap-aging-mouse-brain-v3-20260402) 🔄
- [Gene expression changes in aging mouse brain predicting neurodegenerative vulnerability](/analysis/SDA-2026-04-02-gap-aging-mouse-brain-v4-20260402) 🔄
- [Gene expression changes in aging mouse brain predicting neurodegenerative vulnerability](/analysis/SDA-2026-04-02-gap-aging-mouse-brain-v5-20260402) 🔄
Pathway Diagram
The following diagram shows the key molecular relationships involving Brain Volume Changes in Early Alzheimer's Disease discovered through SciDEX knowledge graph analysis:
Mermaid diagram (expand to render)